Literature DB >> 17262716

Long-term intrapatient viral evolution during HIV-2 infection.

Adam MacNeil1, Jean-Louis Sankale, Seema Thakore Meloni, Abdoulaye Dieng Sarr, Souleymane Mboup, Phyllis Kanki.   

Abstract

Background. Disease progression and transmission of human immunodeficiency virus (HIV) type 2 are attenuated, compared with HIV-1, which is consistent with the lower plasma viral loads observed in HIV-2 infection. Although numerous studies have characterized the intrapatient evolution of viral sequences during HIV-1 infection, prospective studies examining intrapatient evolution during HIV-2 infection have been limited.Methods. We examined viral sequence evolution in the C2V3C3 region of the viral env gene in 8 HIV-2-infected individuals from Dakar, Senegal, over the course of approximately 10 years. To compare results with HIV-1 infection, we reanalyzed data from our previous study that prospectively examined intrapatient viral evolution in HIV-1-infected individuals from the same population.Results. HIV-2 sequences from early and late time points were phylogenetically intermixed for all subjects. No distinct trends were observed in terms of increases or decreases in fragment size or the number of N-linked glycosylation sites, and ratios of synonymous substitutions per synonymous site to nonsynonymous substitutions per nonsynonymous site suggested selection to be neutral or negative. In homologous env C2V3 sequences, rates of viral divergence and diversification were slower in individuals infected with HIV-2 than in those infected with HIV-1.Conclusions. Viral evolution occurs slowly in HIV-2 infection, which is consistent with the slow disease progression of HIV-2 and supports the notion that viral evolution may be a relevant correlate for disease progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17262716     DOI: 10.1086/511308

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients.

Authors:  Helena Skar; Pedro Borrego; Timothy C Wallstrom; Mattias Mild; José Maria Marcelino; Helena Barroso; Nuno Taveira; Thomas Leitner; Jan Albert
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

2.  Many human RNA viruses show extraordinarily stringent selective constraints on protein evolution.

Authors:  Jinn-Jy Lin; Maloyjo Joyraj Bhattacharjee; Chun-Ping Yu; Yan Yuan Tseng; Wen-Hsiung Li
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-04       Impact factor: 11.205

3.  Variation in Intra-individual Lentiviral Evolution Rates: a Systematic Review of Human, Nonhuman Primate, and Felid Species.

Authors:  Emma Krakoff; Roderick B Gagne; Sue VandeWoude; Scott Carver
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

4.  Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection.

Authors:  Adam MacNeil; Abdoulaye Dieng Sarr; Jean-Louis Sankalé; Seema Thakore Meloni; Souleymane Mboup; Phyllis Kanki
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

5.  Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infection.

Authors:  Wim Jennes; Makhtar Camara; Tandakha Dièye; Souleymane Mboup; Luc Kestens
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

6.  Structure of an HIV-2 gp120 in Complex with CD4.

Authors:  Yunji W Davenport; Anthony P West; Pamela J Bjorkman
Journal:  J Virol       Date:  2015-11-25       Impact factor: 5.103

7.  A 5'UTR-spliced mRNA isoform is specialized for enhanced HIV-2 gag translation.

Authors:  Christy L Strong; Jean-Marc Lanchy; Abdoulaye Dieng-Sarr; Phyllis J Kanki; J Stephen Lodmell
Journal:  J Mol Biol       Date:  2009-06-23       Impact factor: 5.469

Review 8.  Delayed disease progression in HIV-2: the importance of TRIM5α and the retroviral capsid.

Authors:  M T Boswell; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2019-03-21       Impact factor: 4.330

9.  Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes.

Authors:  Thushan I de Silva; Marlén Aasa-Chapman; Matthew Cotten; Stéphane Hué; James Robinson; Frederic Bibollet-Ruche; Ramu Sarge-Njie; Neil Berry; Assan Jaye; Peter Aaby; Hilton Whittle; Sarah Rowland-Jones; Robin Weiss
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

10.  Non-random pre-transcriptional evolution in HIV-1. A refutation of the foundational conditions for neutral evolution.

Authors:  Carlos Y Valenzuela
Journal:  Genet Mol Biol       Date:  2009-01-30       Impact factor: 1.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.